trending Market Intelligence /marketintelligence/en/news-insights/trending/jQkiMOYMxm_OxqC_KPizzw2 content esgSubNav
In This List

RXi Pharmaceuticals to sell up to $15M of common stock to Chicago-based fund

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


RXi Pharmaceuticals to sell up to $15M of common stock to Chicago-based fund

RXi Pharmaceuticals Corp. agreed to sell up to $15 million worth of its common shares to Chicago-based investor Lincoln Park Capital Fund LLC over a 30-month period.

RXi will control the timing of any future investment under the deal, and Lincoln Park Capital will be obligated to make purchases under the agreement.

The purchase price will be based on the market price of the shares at the time of each sale to Lincoln Park Capital, and there are no upper limits to the price Lincoln Park Capital may pay for the shares.

The company will use the proceeds for working capital and general corporate purposes, including advancing its immuno-oncology pipeline, RXi said in a news release.